Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg and 200 mg, a therapeutic equivalent generic version of Lamictal ODT (lamotrigine) Orally Disintegrating Tablets in the United States market approved by the US Food & Drug Administration (USFDA).

Dr. Reddy’s Lamotrigine Orally Disintegrating Tablets 25 mg, 50 mg, 100 mg and 200 mg are available in bottle count sizes of 30s. The Lamictal ODT brand and generic had US sales of approximately $65.5 million MAT for the most recent twelve months ending in July 2016, according to IMS Health. Lamictal ODT is a registered trademark of GSK group of companies.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.